BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,363.20
      0.49%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.45
      0.00%
      Bitcoin
      92,077.41
      0.11%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Larimar Therapeutics Inc (LRMR) Quote

      Larimar Therapeutics Inc

      Larimar Therapeutics Inc (LRMR)

      NASDAQ
      6.18
      -0.15
      (-2.37%)
      At close: November 26 4:00PM
      Delayed by 15 minutes
      6.23
      0.05
      ( 0.81% )
      After Hours: 6:56PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      6.23
      Bid
      6.10
      Ask
      6.25
      Volume
      746,386
      6.13 Day's Range 6.53
      3.19 52 Week Range 13.68
      Market Cap
      397.515M
      Previous Close
      6.33
      Open
      6.53
      Last Trade
      47
      @
      6.25
      Last Trade Time
      18:57:02
      Financial Volume
      $ 4,659,885
      VWAP
      6.2433
      Average Volume (3m)
      749,238
      Shares Outstanding
      63,806,628
      Dividend Yield
      -
      PE Ratio
      -1.71
      Earnings Per Share (EPS)
      -0.58
      Revenue
      -
      Net Profit
      -36.95M

      About Larimar Therapeutics Inc

      Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion p... Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      larimartx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Larimar Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LRMR. The last closing price for Larimar Therapeutics was $6.33. Over the last year, Larimar Therapeutics shares have traded in a share price range of $ 3.19 to $ 13.68.

      Larimar Therapeutics currently has 63,806,628 shares outstanding. The market capitalization of Larimar Therapeutics is $403.90 million. Larimar Therapeutics has a price to earnings ratio (PE ratio) of -1.71.

      Ask ADVFN Intelligence (AI)

      LRMR Latest News

      More News

      FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

      11 hours ago

      FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

      12 hours ago

      Form 8-K - Current report

      November 18 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      October 30 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 30 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 10 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.182.975206611576.056.65.686039876.22037151CS
      4-1.7233-21.66773540547.95339.55.687566027.68191912CS
      12-1.63-20.7379134867.869.55.687492387.30918293CS
      26-0.86-12.12976022577.0911.25.686146967.79070687CS
      522.776.48725212463.5313.683.195352528.16497986CS
      156-4.05-39.396887159510.2813.681.533019996.44944745CS
      260-5.77-48.08333333331225.871.532265297.21314335CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      IFBDInfobird Company Ltd
      $ 3.42
      (87.91%)
      		4.6M
      IDAIT Stamp Inc
      $ 0.5011
      (37.29%)
      		12.63M
      AMBAAmbarella Inc
      $ 84.40
      (23.37%)
      		733.37k
      HWHHWH International Inc
      $ 0.67
      (18.58%)
      		9.9k
      CYCNCyclerion Therapeutics Inc
      $ 1.5995
      (17.61%)
      		48.78k
      PGHLPrimega Group Holdings Ltd
      $ 12.27
      (-88.57%)
      		2.15M
      MONDMondee Holdings Inc
      $ 0.7499
      (-21.71%)
      		21.09k
      IMGCIMG Inc
      $ 1.29
      (-19.38%)
      		3.48M
      BSFCBlue Star Foods Corporation
      $ 0.3078
      (-16.81%)
      		2.9M
      ZENAZenaTech Inc
      $ 8.80
      (-14.56%)
      		985.22k
      ELABElevai Labs Inc
      $ 0.0126
      (0.80%)
      		31.59M
      IDAIT Stamp Inc
      $ 0.5011
      (37.29%)
      		12.63M
      IGFiShares Global Infrastructure
      $ 55.25
      (0.00%)
      		4.76M
      IFBDInfobird Company Ltd
      $ 3.42
      (87.91%)
      		4.6M
      NVDANVIDIA Corporation
      $ 136.3607
      (-0.41%)
      		3.55M

      LRMR Discussion

      View Posts
      tw0122 tw0122 5 months ago
      LRMR above $9 momentarily
      👍️0
      Monksdream Monksdream 7 months ago
      LRMR under $10

      👍️0
      Monksdream Monksdream 8 months ago
      LRMR under $10
      👍️0
      Monksdream Monksdream 9 months ago
      LRMR new 52 week high
      👍️0
      Monksdream Monksdream 9 months ago
      LRMR new 52=week high
      👍️0
      AJ Freely AJ Freely 1 year ago
      $LRMR - Announced that the FDA has cleared the Company’s four-week, placebo-controlled, Phase 2 dose exploration trial of CTI-1601
      👆Up 8% Pre-Market/ Current Price $3,40
      👍️0
      magacrew2020 magacrew2020 2 years ago
      could probably get through approval on just 25 mg if they are going to approve reta
      👍️0
      subslover subslover 2 years ago
      The company said it received feedback from the FDA on information needed to resolve CTI-1601's current clinical hold, as well as a proposed change for a second phase. CTI-1601 is a treatment for Friedreich's ataxia.

      Larimer plans to submit a complete response to CTI-1601's clinical hold in the third quarter.

      Larimar is also proposing a phase two, four-week dose exploration study in Friedreich's ataxia patients. Friedreich's ataxia is a rare disease that causes progressive nervous system damage and movement problems, usually beginning during childhood.
      👍️0
      JJJ54 JJJ54 3 years ago
      I voted NO on the 2022 Annual Meeting Vote. I recommend you do the same.
      👍️0
      DarkPool DarkPool 3 years ago
      Interesting.
      👍️0
      oxnous oxnous 4 years ago
      Waking up . But volume should be higher.
      👍️0
      DewDiligence DewDiligence 4 years ago
      LRMR 2Q20 results—6/30/20 cash=$113.7M:

      https://www.globenewswire.com/news-release/2020/08/11/2076240/0/en/Larimar-Therapeutics-Reports-Second-Quarter-2020-Operating-and-Financial-Results.html

      No CC.
      👍️0
      casenumber casenumber 5 years ago
      Large chunks are being gobbled
      Whales are lurking around?
      👍️0
      subslover subslover 5 years ago
      The company they are merging with looks pretty darn impressive
      https://chondrialtherapeutics.com/
      👍️0
      casenumber casenumber 5 years ago
      Volume!
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $ZFGN Video Chart 12-26-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $ZFGN Video Chart 12-24-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      whytestocks whytestocks 5 years ago
      News: $ZFGN Penny Stocks To Buy Or Sell Before The End Of 2019?

      These Penny Stocks Moved Big But Can They Continue Higher Before Next Year? Over the course of the year, plenty of penny stocks have generated significant gains for investors. Even as the year comes to a close, there are some penny stocks that are gaining momentum. It is often said that inve...

      Got this from ZFGN - Penny Stocks To Buy Or Sell Before The End Of 2019?
      👍️0
      Fat Thor Fat Thor 5 years ago
      Like I said at .67 cents
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $ZFGN Video Chart 12-23-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      casenumber casenumber 5 years ago
      Wow...guess they will satisfy the 1dollar minimum nasd requirement with out rs.....
      This will be huge when ticker change and merger consummated next month!

      Scrap the notice of delisting boys.....

      82M cash and 30M OS....sounds fun!
      👍️0
      ClayTrader ClayTrader 5 years ago
      * * $ZFGN Video Chart 12-20-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      casenumber casenumber 5 years ago
      Over a buck soon when ticker change completed....
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      exactly is great
      👍️0
      Fat Thor Fat Thor 5 years ago
      Probably 3-9 months away still - appears to be a massive over correction and tax loss selling on the merger news. Just a short target at the moment. They will run this in Q1 pre-split to get a much more favorable ratio IMO. Let's see what happens. Lots of cash on hand here at very low burn rate per Q.

      The transaction is expected to close in the first half of 2020, subject to approvals by stockholders of each company and other customary closing conditions.
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      R/Split coming per 8k today
      👍️0
      Fat Thor Fat Thor 5 years ago
      December discounts. With 85 million in cash, a merger, and priced at 67 cents there's no way this doesn't run soon. 35 million O/S.
      👍️0
      casenumber casenumber 5 years ago
      Ticker change coming...Shorts will get burn if they will not cover or do damage control.
      ZFGN has 82M dollars in cash!

      The proposed merger will result in a combined publicly traded, clinical-stage biopharmaceutical company operating under a new name, Larimar Therapeutics, Inc.
      👍️0
      casenumber casenumber 5 years ago
      Shorts covering.. they have to before it gets out of control once the merger is official...
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      10 day MA live chart huge oversold,safe here now,will recover nice
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      bought 3k at 6391
      👍️0
      Fat Thor Fat Thor 5 years ago
      Just saw a bunch come through on tape that were vastly different but didn't indicate "out of sequence"...they were either out of sequence or it was a messed up market order. Just odd. This one is clearly under short attack. Volume could squeeze it near term.
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      ZFGN~~Balance Sheet
      Total Cash (mrq) 82.01M
      Total Cash Per Share (mrq) 2.19
      Total Debt (mrq) 24.35M
      Total Debt/Equity (mrq) 40.67
      Current Ratio (mrq) 5.11
      Book Value Per Share (mrq) 1.60
      https://finance.yahoo.com/quote/ZFGN/key-statistics?p=ZFGN



      👍️0
      alchemytrader alchemytrader 5 years ago
      not really. that would mean its been up and down, up and down. this is nothing but down..
      👍️0
      Fat Thor Fat Thor 5 years ago
      ...this price action is ALL over the place. Crazy.
      👍️0
      alchemytrader alchemytrader 5 years ago
      man i hope so. just want out even now
      👍️0
      BoilerRoom BoilerRoom 5 years ago
      $ZFGN in at .70
      👍️0
      BoilerRoom BoilerRoom 5 years ago
      Short this
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      will recover but sucks,waste of time
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      Zafgen and Chondrial Therapeutics will host an investor conference call today, December 18, 2019, at 8:30 a.m.,
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      Conference Call Information
      Zafgen and Chondrial Therapeutics will host an investor conference call today, December 18, 2019, at 8:30 a.m., Eastern Time, to discuss the merger as well as other forward-looking information. Investors and other interested parties may participate by dialing (844) 824-7428 in the United States or (973) 500-2177 outside the United States and referencing conference ID number 5688136. The call will also be webcast live on the Company's website at https://zafgen.gcs-web.com/events-and-presentations. A replay of this conference call will be available beginning at 11:30 a.m. ET on December 18, 2019 through December 25, 2019 by dialing (855) 859-2056 in the United States or (404) 537-3406 outside the United States. To access the replay please provide Conference ID number 5688136.
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      dont think so
      👍️0
      Widowsson32 Widowsson32 5 years ago
      This is done no benefit to this company but ONTX will make you very rich
      👍️0
      alchemytrader alchemytrader 5 years ago
      institutions selling off?
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      the news is great,why?
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      fffffffffffffffffff MMS
      👍️0
      alchemytrader alchemytrader 5 years ago
      i guess were screwed
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      f MMs
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      .79 f
      👍️0
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
      what the heck is going on here?
      👍️0

      Your Recent History

      NASDAQ
      LRMR
      Larimar Therapeutics
      Delayed Upgrade Clock